<DOC>
	<DOCNO>NCT00770666</DOCNO>
	<brief_summary>Randomized clinical trial evaluate flexibly-dosed-3-medication combination 6 month smoker medical illness</brief_summary>
	<brief_title>Combination Medications vs. Patch Alone Medically-Ill Smokers</brief_title>
	<detailed_description>Subjects randomly receive either nicotine patch alone 10-week , taper course ( n=64 ) combination nicotine patch , nicotine oral inhaler , bupropion ad-lib duration ( n=63 ) .</detailed_description>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>currently smoke least 10 cigarette per day ( confirm high exhale carbonmonoxide ( CO ) ) 18 year older interested quit within next 30 day one predefined medical illness ( include cardiovascular disease , vascular disease , chronic pulmonary disease , cancer , hypertension , diabetes , hyperlipidemia , recurrent pulmonary infection ) contraindication pharmacotherapy ( include unstable angina , myocardial infarction within 2 month , severe arrhythmia , seizure disorder , serious mental illness require antipsychotic medication ) current use tobacco product ( smokeless tobacco , cigar , pipe , etc . ) , bupropion , clonidine , nortriptyline , nicotine replacement medication unable give consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Tobacco dependence treatment</keyword>
</DOC>